A new trading day began on Monday, with Summit Therapeutics Inc (NASDAQ: SMMT) stock price up 10.19% from the previous day of trading, before settling in for the closing price of $16.19. SMMT’s price has ranged from $15.55 to $36.91 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -10.52% over the past five years. Meanwhile, its annual earnings per share averaged -318.04%. With a float of $102.73 million, this company’s outstanding shares have now reached $744.44 million.
Summit Therapeutics Inc (SMMT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Summit Therapeutics Inc is 86.17%, while institutional ownership is 14.12%. The most recent insider transaction that took place on Oct 21 ’25, was worth 9,999,983. In this transaction Director of this company bought 533,617 shares at a rate of $18.74, taking the stock ownership to the 32,057,147 shares. Before that another transaction happened on Oct 21 ’25, when Company’s Co-Chief Executive Officer bought 26,680 for $18.74, making the entire transaction worth $499,983. This insider now owns 76,680 shares in total.
Summit Therapeutics Inc (SMMT) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.06 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
Summit Therapeutics Inc (NASDAQ: SMMT) Trading Performance Indicators
Here are Summit Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.91 in one year’s time.
Technical Analysis of Summit Therapeutics Inc (SMMT)
Summit Therapeutics Inc (NASDAQ: SMMT) saw its 5-day average volume 2.77 million, a negative change from its year-to-date volume of 3.72 million. As of the previous 9 days, the stock’s Stochastic %D was 30.00%.
During the past 100 days, Summit Therapeutics Inc’s (SMMT) raw stochastic average was set at 14.45%, which indicates a significant decrease from 58.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.94 in the past 14 days, which was lower than the 1.35 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.51, while its 200-day Moving Average is $22.11. Nevertheless, the first resistance level for the watch stands at $18.45 in the near term. At $19.06, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.17. If the price goes on to break the first support level at $16.73, it is likely to go to the next support level at $15.62. The third support level lies at $15.01 if the price breaches the second support level.
Summit Therapeutics Inc (NASDAQ: SMMT) Key Stats
With a market capitalization of 13.25 billion, the company has a total of 771,150K Shares Outstanding. Currently, annual sales are 0 K while annual income is -221,320 K. The company’s previous quarter sales were 0 K while its latest quarter income was -231,790 K.
